Federal-Led Models for Lowering Costs & Improving Access to Gene Therapies (Virtual)
Time: 8:30 am
day: Day Two AM
Details:
- Exploring key goals for the Center for Medicare and Medicaid Innovation’s (CMMI) ‘Cell & Gene Therapy Access’ model
- How are the CMMI approaching quality measurement for gene therapies, including patient-reported outcomes?
- Addressing the short- and long- term implications of these two models for gene therapy drug developers
- Considerations for what reimbursement pathway for gene therapies actually looks like
